Stephen Hodi, MD
F. Stephen Hodi is director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center, the Sharon Crowley Martin Chair in Melanoma at Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School. His research focuses on the development of immune therapies, and first into human studies for malignant melanoma. Steve is a member of the American Society of Clinical Oncology, the Eastern Cooperative Oncology Group Melanoma Committee, the Society for Immunotherapy of Cancer, and a founding member of the Society for Melanoma Research. He received his medical degree from Cornell University Medical College. Steve completed his postdoctoral training in Internal Medicine at the Hospital of the University of Pennsylvania, and Medical Oncology training at Dana-Farber Cancer Institute.